Ads
related to: intermittent explosive disorder clinical trials research alliance jobsEmployment.org has been visited by 100K+ users in the past month
- Contract Cra Jobs
Contract Cra Jobs in Your Area
New: Contract Cra Jobs
- Clinical Research Jobs
Clinical Research Jobs in Your Area
New: Clinical Research Jobs
- Trial Application
Fill Out Application
Apply Now
- Research Coordinator Jobs
Coordinator Jobs in Your Area
New: Research Coordinator Jobs
- Contract Cra Jobs
Search results
Results from the WOW.Com Content Network
SRX246, also known as API-246, is a small-molecule, centrally-active, highly-selective vasopressin V 1A receptor antagonist which is under investigation by Azevan Pharmaceuticals for the treatment of affective and anger disorders.
This is a list of investigational aggression drugs, or drugs that are currently under development for clinical use in the treatment of aggression but are not yet approved. Drugs used to treat aggression may also be known as "serenics". [1]
Intermittent explosive disorder (IED), or episodic dyscontrol syndrome (EDS), is a mental and behavioral disorder characterized by explosive outbursts of anger or violence, often to the point of rage, that are disproportionate to the situation at hand (e.g., impulsive shouting, screaming, or excessive reprimanding triggered by relatively inconsequential events).
Intermittent explosive disorder or IED is a clinical condition of experiencing recurrent aggressive episodes that are out of proportion of any given stressor. Earlier studies reported a prevalence rate between 1–2% in a clinical setting, however a study done by Coccaro and colleagues in 2004 had reported about 11.1% lifetime prevalence and 3. ...
A clinical research associate (CRA), also called a clinical monitor or trial monitor, is a health-care professional who performs many activities related to medical research, particularly clinical trials. Clinical research associates work in various settings, such as pharmaceutical companies, medical research institutes and government agencies.
Detailed protocols for proposed clinical studies to assess whether the initial-phase trials will expose the subjects to unnecessary risks. Other commitments are commitments to obtain informed consent from the research subjects, to obtain a review of the study by an institutional review board (IRB), and to adhere to the investigational new drug ...
Science 37 was founded in 2014 [3] by Noah Craft and Belinda Tan, working out of LA BioMed at Harbor-UCLA Medical Center. [4]Their team developed the Network Oriented Research Assistant platform, also known as the NORA platform, which includes video chat, digital self-photography, data collection, and electronic consent.
Here are links to possibly useful sources of information about Intermittent explosive disorder. PubMed provides review articles from the past five years (limit to free review articles) The TRIP database provides clinical publications about evidence-based medicine. Other potential sources include: Centre for Reviews and Dissemination and CDC
Ads
related to: intermittent explosive disorder clinical trials research alliance jobsEmployment.org has been visited by 100K+ users in the past month